Qingfeng Shi

887 total citations · 1 hit paper
18 papers, 592 citations indexed

About

Qingfeng Shi is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Qingfeng Shi has authored 18 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Qingfeng Shi's work include Helicobacter pylori-related gastroenterology studies (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Probiotics and Fermented Foods (2 papers). Qingfeng Shi is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Probiotics and Fermented Foods (2 papers). Qingfeng Shi collaborates with scholars based in China, Canada and United States. Qingfeng Shi's co-authors include Bijie Hu, Zheyong Huang, Zhe Luo, Sisi Chen, Jiatian Cao, Kai Liu, Yumeng Yao, Xiang Chen, Kaihuan Yu and Qingqing Wang and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Frontiers in Microbiology.

In The Last Decade

Qingfeng Shi

18 papers receiving 579 citations

Hit Papers

D-dimer as a biomarker for disease severity and mortality... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingfeng Shi China 8 383 143 100 84 79 18 592
Luisa Marchioni Italy 14 496 1.3× 213 1.5× 75 0.8× 155 1.8× 97 1.2× 26 750
Lianfeng Lu China 8 554 1.4× 260 1.8× 97 1.0× 72 0.9× 85 1.1× 21 758
Vsevolod Zinserling Russia 10 300 0.8× 182 1.3× 33 0.3× 86 1.0× 110 1.4× 47 639
Zhaohui Tong China 8 295 0.8× 99 0.7× 72 0.7× 45 0.5× 90 1.1× 27 555
Paul Chui Singapore 9 625 1.6× 230 1.6× 135 1.4× 92 1.1× 112 1.4× 15 878
Huaqin Pan China 11 509 1.3× 272 1.9× 156 1.6× 132 1.6× 116 1.5× 30 776
Simone Bastrup Israelsen Denmark 14 170 0.4× 79 0.6× 58 0.6× 30 0.4× 114 1.4× 31 452
Jinya Ding China 7 649 1.7× 343 2.4× 64 0.6× 135 1.6× 116 1.5× 13 870
Scott C. Roberts United States 12 125 0.3× 85 0.6× 45 0.5× 55 0.7× 159 2.0× 42 598

Countries citing papers authored by Qingfeng Shi

Since Specialization
Citations

This map shows the geographic impact of Qingfeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Shi more than expected).

Fields of papers citing papers by Qingfeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Shi. The network helps show where Qingfeng Shi may publish in the future.

Co-authorship network of co-authors of Qingfeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Shi. A scholar is included among the top collaborators of Qingfeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Shi. Qingfeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Fan, et al.. (2024). The characteristics of intestinal microbiota in patients with type 2 diabetes and the correlation with the percentage of T-helper cells. Frontiers in Microbiology. 15. 1443743–1443743. 2 indexed citations
2.
Zhang, Li, et al.. (2021). Using a non-invasive multi-sensor device to evaluate left atrial pressure: an estimated filling pressure derived from ballistocardiography. Annals of Translational Medicine. 9(20). 1587–1587. 6 indexed citations
3.
Jin, Wenting, Yuyan Ma, Qingfeng Shi, et al.. (2021). Clinical features of and diagnostic approaches for abdominal tuberculosis: 5-year experience from a non-tuberculosis-designated hospital in China. Revista Española de Enfermedades Digestivas. 114(8). 461–467. 1 indexed citations
4.
Zhang, Li, et al.. (2021). Ballistocardiography to identify high left atrial pressure in patients with heart failure. Annals of Palliative Medicine. 10(7). 8155–8168. 6 indexed citations
5.
Zhang, Li, et al.. (2020). BALLISTOCARDIOGRAPHY TO IDENTIFY HIGH LEFT ATRIAL PRESSURE IN PATIENTS WITH HEART FAILURE. Journal of the American College of Cardiology. 75(11). 1056–1056. 1 indexed citations
6.
Gao, Xiaodong, et al.. (2020). Increased multidrug resistant isolates: new clinical burdens for 66 hospitals in Shanghai, 2015 to 2017. Annals of Translational Medicine. 8(4). 112–112. 12 indexed citations
7.
Bao, Rong, Yao Xiao, Wei Sun, et al.. (2020). Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Frontiers in Cellular and Infection Microbiology. 10. 12–12. 11 indexed citations
8.
Yao, Yumeng, Jiatian Cao, Qingqing Wang, et al.. (2020). D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of Intensive Care. 8(1). 49–49. 409 indexed citations breakdown →
9.
Su, Yi, Yun Ling, Lili Tao, et al.. (2020). Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China. BioScience Trends. 14(6). 408–414. 5 indexed citations
10.
Gao, Xiaodong, Wei Sun, Yan Shen, et al.. (2019). A survey of sharps injuries and occupational infections among healthcare workers in Shanghai. Annals of Translational Medicine. 7(22). 678–678. 15 indexed citations
11.
Shi, Qingfeng, et al.. (2018). Knowledge and practice of Chinese physicians toward carbapenem-resistant enterobacteriaceae: a nationwide cross-sectional survey in top 100 hospitals. Journal of Thoracic Disease. 10(7). 4396–4402. 3 indexed citations
12.
Zhang, Rongguang, et al.. (2018). Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice. Biotechnology Letters. 40(3). 585–590. 17 indexed citations
13.
Li, Rui, Hexing Wang, Qingfeng Shi, et al.. (2017). Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice. PLoS ONE. 12(7). e0181690–e0181690. 61 indexed citations
14.
Zhang, Rongguang, Guangcai Duan, Qingfeng Shi, et al.. (2017). A novel food‐grade lactococcal expression system and its use for secretion and delivery of an oral vaccine antigen. Journal of Chemical Technology & Biotechnology. 93(6). 1655–1660. 1 indexed citations
15.
Zhang, Rongguang, Guangcai Duan, Qingfeng Shi, et al.. (2016). An engineered Lactococcus lactis strain exerts significant immune responses through efficient expression and delivery of Helicobacter pylori Lpp20 antigen. Biotechnology Letters. 38(12). 2169–2175. 19 indexed citations
16.
Zhang, Rongguang, Guangcai Duan, Qingfeng Shi, et al.. (2016). Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development. Biotechnology Letters. 38(11). 1911–1916. 16 indexed citations
17.
Shi, Qingfeng, et al.. (2016). Biological Characteristics of H9N2 Avian Influenza Viruses from Healthy Chickens in Shanghai, China. Medical Science Monitor. 22. 4844–4853. 4 indexed citations
18.
Chen, Min, Mingli Peng, Qingfeng Shi, & Hong Ren. (2007). [Establishing a L02 cell model with whole HBV gene transfection and analyzing its expressions of HLA-A, B, C and MICA/B].. PubMed. 15(6). 417–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026